MSTR heads into its July 30 earnings print with one clear change from last week: options traders have swung decisively toward calls, even as short sellers quietly added to positions.
The options story is the sharpest development this week. The put/call ratio has dropped to 0.91 — more than two standard deviations below its 20-day average of 1.01, making it the most call-heavy reading relative to recent norms in the observable window. That's a notable reversal from the defensive posture that has characterised most of the past six weeks, where the PCR rarely dipped below 1.0. The stock itself closed at $97.58 on Tuesday, up 6% on the day after a near-flat week overall — the daily bounce suggesting some tactical positioning ahead of the result rather than a sustained re-rating.
Short interest tells a more cautious story. The SI % of free float has crept back up to 15.1%, with roughly 2.8% added on the week — reversing the gentle drift lower described in last week's note. That's a meaningful rebuild: 40.5 million shares short, close to the levels seen through June. The borrow market itself remains relaxed. Availability is running at roughly 247% of short interest — looser than the 225% reading from a week ago — and cost to borrow is a negligible 0.56%. There is no squeeze pressure here. New shorts can be established easily and cheaply, which partly explains why the position has grown without any sign of forced covering.
The Street consensus is formally bullish, but analysts have spent the past two weeks cutting targets aggressively. Barclays initiated coverage this week at Overweight with a $130 target — a positive rating, but one that essentially anchors the stock close to where it already trades. Mizuho lowered its target to $213 from $265 while maintaining Outperform; Citigroup cut from $260 to $136; BTIG and TD Cowen both trimmed heavily. The mean target of $304 implies substantial upside on paper, but the direction of travel is clearly downward. Bulls point to Strategy's unique position as the largest public corporate Bitcoin holder and its growing software segment. Bears counter that the capital structure is fragile — the STRC preferred equity has weakened under BTC price pressure, and the company's convertible debt manoeuvres have consumed the USD reserve that once served as a buffer.
Institutional ownership adds an interesting wrinkle. Capital Research and Management lifted its stake to 12.3% of shares as of June 30, adding over 12.8 million shares in the most recent reported period. BlackRock also added 3.1 million shares in the same window. Both moves are large enough to be intentional rather than index-driven, and they sit alongside founder Michael Saylor's unchanged 5.7% holding. Insider activity from below the C-suite has been uniformly one-directional — director Jarrod Patten sold 4,500 shares across three transactions in June at prices between $106 and $134, all well above current levels.
The earnings history is thin but not alarming: the June 8 print produced a 2.8% one-day decline followed by an 8.9% five-day recovery; the May 5 event went the other direction, up 1.6% on the day and essentially flat across the week. Neither reading suggests a reliably large directional move, but both came at higher stock prices. What the July 30 release will clarify is whether the aggressive analyst target cuts have correctly anticipated deterioration in the software business fundamentals, or whether the Bitcoin-per-share story — which the bull case emphasises — has improved enough to narrow the gap between where the stock sits and where institutional buyers think it belongs.
See the live data behind this article on ORTEX.
Open MSTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
